Drugs Used in Conscious Sedation in Pediatric Dentistry

1. Inhalational Agent

Nitrous Oxide / Oxygen (N₂O/O₂)

• Preferred first-line agent per EAPD guidelines - the most widely recommended drug for conscious sedation in pediatric dentistry
• Maximum concentration: 50% N₂O with the balance as oxygen
• Provides anxiolysis, mild analgesia, and amnesia
• Rapid onset and rapid recovery (unique advantage over all other agents)
• Child must accept a nasal hood and breathe nasally
• Often combined with other agents (e.g., midazolam) for additive effect
• A 10-year retrospective study of 819 pediatric patients found it the most effective and safe sedation agent

2. Benzodiazepines

Midazolam (Most commonly used BZD)

• Gold-standard benzodiazepine for conscious sedation in pediatric dentistry
• Multiple routes: oral, intranasal (via mucosal atomizer), IV, IM, rectal
• Oral dose: 0.25-0.5 mg/kg (peak plasma concentration within 20 minutes orally)
• Intranasal route: rapid absorption, non-invasive, useful for uncooperative children; may cause nasal irritation and bitter taste
• Provides anxiolysis, sedation, and amnesia (anterograde)
• No analgesic effect - must be combined with local anesthesia
• A 2025 systematic review (PMID: 41121658) confirms efficacy of midazolam for outpatient pediatric dentistry

Diazepam

• An alternative BZD for pediatric dental sedation (longer acting than midazolam)
• Less preferred than midazolam due to longer half-life and less predictable onset
• Oral and IV routes

Triazolam

• Classified as a hypnotic benzodiazepine
• Used in pediatric dentistry but fewer efficacy studies in children compared to midazolam

3. Antihistamines

Hydroxyzine

• A histamine H1-blocker with sedative, antiemetic, anticonvulsant, and anticholinergic properties
• Onset: 15-30 minutes orally
• Not effective alone for deep sedation, but highly synergistic with midazolam
• Midazolam + hydroxyzine is a very popular combination in pediatric dentistry - children more likely to exhibit quiet/sleep behavior than with midazolam alone
• Also combined with nitrous oxide
• Classified as a moderate-risk drug; does not produce the same level of respiratory depression as narcotics

Promethazine

• Phenothiazine antihistamine with sedative properties
• Used in combination with nitrous oxide (nitrous oxide/promethazine vs. nitrous oxide/midazolam have been directly compared)
• Less commonly used now due to risk of paradoxical excitation

4. Alpha-2 Adrenergic Agonists (Newer Agents)

Dexmedetomidine

• Highly selective alpha-2 agonist with sedative, analgesic, and anxiolytic properties
• Routes: intranasal (most common in dentistry), IV, buccal
• Advantage: longer working time than midazolam for dental procedures
• Less respiratory depression than benzodiazepines or narcotics
• Increasingly used as a newer alternative; intranasal dexmedetomidine shows promising safety and efficacy results
• Studied in combinations: dexmedetomidine + midazolam, dexmedetomidine + ketamine (buccal)
• Still limited high-quality research specific to pediatric dentistry, but results are promising

5. Dissociative Agents

Ketamine

• Dissociative anesthetic producing sedation, analgesia, and amnesia while maintaining airway reflexes
• Routes: oral, IM, IV, intranasal
• Used as an adjunct (e.g., midazolam + ketamine, dexmedetomidine + ketamine)
• Per EAPD guidelines, use in pediatric dentistry is still considered "experimental" and requires an anesthesiologist
• Risks: increased secretions (co-administer with anticholinergic), emergence reactions (mitigated by co-administering midazolam), laryngospasm

6. Opioids

Fentanyl

• Short-acting opioid; used intravenously, intranasally, or transmucosally
• Provides analgesia in addition to sedation
• Often combined with midazolam: fentanyl + midazolam (small IV doses)
• Risk of respiratory depression - requires monitoring
• Per EAPD, "efficacy is questionable and associated risks may outweigh benefit" for routine outpatient use; recommended only in hospital settings

Morphine Sulfate

• Used in triple-drug regimens (e.g., oral benzodiazepine + hydroxyzine + oral morphine sulfate)
• 80% success rate reported in one study, though airway compromise monitoring is needed

Pethidine (Meperidine)

• Historically used but now discouraged due to toxic metabolite (normeperidine) accumulation
• Per EAPD guidelines, risks may outweigh benefits for outpatient pediatric dental sedation

7. Chloral Hydrate

• A sedative-hypnotic historically widely used in pediatric dentistry (oral/rectal)
• Still used in some settings, especially for very young children
• Narrow therapeutic window, long duration of action, and unpredictable sedation depth
• Falls out of favor in many countries due to safety concerns; classified as a carcinogen in some jurisdictions
• Usually combined with hydroxyzine and/or promethazine in multi-drug protocols

8. Barbiturates

Pentobarbital / Secobarbital

• Older sedative-hypnotics used in pediatric sedation protocols
• Primarily used in hospital or radiology settings
• Less predictable than benzodiazepines; longer recovery; no reversal agent
• Rarely used in modern outpatient pediatric dentistry

9. Local Anesthetics (Mandatory Adjunct)

Lidocaine, Articaine, Mepivacaine, Bupivacaine

• Not sedatives per se, but essential components of any conscious sedation protocol in dentistry
• Provide operative analgesia that cannot be achieved by sedatives alone (benzodiazepines have no analgesic effect)
• Topical local anesthetics (e.g., EMLA, benzocaine gel) are applied before injection to reduce needle pain

Summary Table

• Nitrous oxide + midazolam (most common combination)
• Midazolam + hydroxyzine
• Midazolam + ketamine
• Dexmedetomidine + midazolam
• Triple protocol: midazolam + hydroxyzine + morphine